See What HealthDay Can Do For You
Contact Us

Diclegis Approved for Morning Sickness

Among pregnant women who haven't responded to other treatments

TUESDAY, April 9, 2013 (HealthDay News) -- Diclegis (doxylamine succinate and pyridoxine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting associated with "morning sickness" during pregnancy.

The drug was sanctioned for pregnant women who haven't responded to other therapies, such as eating smaller meals, eating lower-fat foods and avoiding smells that can prompt nausea, the agency said in a media release.

Diclegis was evaluated in 261 adult women with morning sickness who had been pregnant between seven and 14 weeks. Women who took the drug had less nausea and vomiting than those who took a placebo. Studies also showed the drug didn't pose a threat to the fetus, the FDA said.

The most common side effect of the drug -- with a typical once-daily dose of two pills -- was potentially severe drowsiness. Women who take Diclegis should avoid driving or operating heavy machinery, the agency said.

The drug is marketed by the Canadian pharma firm Duchesnay, based in Quebec.

More information

Medline Plus has more about morning sickness.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.